Skip to main content
. 2011 Jan 14;17(2):197–206. doi: 10.3748/wjg.v17.i2.197

Table 3.

Odds ratio for the studied gene polymorphisms in Crohn’s disease and ulcerative colitis patients

CD UC Control ORCD 95% CI1 P value ORUC 95% CI1 P value
NF-κB -94ins/del
II 107 175 267 1.00 - 1.00 -
ID 165 233 385 1.08 0.80-1.46 0.62 0.94 0.72-1.21 0.62
DD 55 87 127 1.21 0.81-1.81 0.36 1.04 0.73-1.47 0.83
ID and DD 220 320 512 1.11 0.83-1.48 0.48 0.96 0.75-1.23 0.76
PPARγ Pro12Ala
CC 240 364 549 1.00 - 1.00 -
CG 84 116 217 0.88 0.65-1.20 0.43 0.83 0.63-1.09 0.17
GG 3 15 13 0.48 0.13-1.77 0.27 2.30 1.04-5.08 0.04
CG and GG 87 131 230 0.86 0.64-1.16 0.33 0.90 0.69-1.17 0.42
PPARγ C1431T
CC 241 352 561 1.00 - 1.00 -
CT 78 128 205 0.81 0.59-1.12 0.20 1.00 0.76-1.31 0.99
TT 8 15 13 1.36 0.54-3.42 0.52 1.95 0.90-4.27 0.09
CT and TT 86 143 218 0.85 0.62-1.15 0.29 1.05 0.81-1.37 0.69
PXR rs1523127
AA 114 160 280 1.00 - 1.00 -
AC 167 250 366 1.06 0.79-1.43 0.71 1.15 0.89-1.50 0.29
CC 46 85 133 0.89 0.59-1.35 0.59 1.11 0.78-1.56 0.57
AC and CC 213 335 499 1.02 0.77-1.35 0.91 1.14 0.89-1.46 0.30
PXR rs2276707
CC 223 339 517 1.00 - 1.00 -
CT 94 147 241 0.92 0.68-1.24 0.57 0.97 0.75-1.26 0.84
TT 10 9 21 1.25 0.56-2.76 0.58 0.67 0.30-1.51 0.33
CT and TT 104 156 262 0.94 0.71-1.26 0.69 0.95 0.74-1.22 0.68
PXR rs6785049
AA 137 184 334 1.00 - 1.00 -
AG 152 247 343 1.12 0.84-1.49 0.46 1.35 1.05-1.74 0.02
GG 38 64 102 0.91 0.58-1.40 0.66 1.18 0.81-1.71 0.39
AG and GG 190 311 445 1.07 0.81-1.40 0.65 1.31 1.03-1.66 0.03
LXR rs1405655
TT 143 229 383 1.00 - 1.00 -
CT 149 217 313 1.26 0.95-1.68 0.11 1.22 0.95-1.57 0.11
CC 35 49 83 1.12 0.71-1.78 0.62 1.01 0.67-1.51 0.97
CT and CC 184 266 396 1.23 0.94-1.62 0.13 1.18 0.93-1.49 0.17
LXR rs2695121
TT 62 88 170 1.00 - 1.00 -
CT 168 254 387 1.28 0.90-1.83 0.17 1.30 0.95-1.77 0.10
CC 97 153 222 1.21 0.82-1.79 0.34 1.41 1.00-1.98 0.05
CT and CC 265 407 609 1.26 0.89-1.76 0.19 1.34 0.99-1.79 0.06

Statistical analyses included subjects for whom all information was available.

1

Adjusted for age, sex and smoking status. NF-κB: Nuclear factor κB; PPARγ: Peroxisome proliferator-activated receptor γ; CD: Crohn’s disease; UC: Ulcerative colitis; OR: Odds ratio; PXR: Pregnane X receptor; LXR: Liver X receptor.